COVIDIEN PLC — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2233f04a-2541-4752-856d-988d5a8689d5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2014 | $10.7B | 2013-09-28 – 2014-09-26 | evidence 0001385187-14-000041 |
| FY 2013 | $10.2B | 2012-09-29 – 2013-09-27 | evidence 0001385187-13-000053 |
| FY 2012 | $11.9B | 2011-10-01 – 2012-09-30 | evidence 0001385187-12-000011 |
| FY 2011 | $11.6B | 2010-09-30 – 2011-09-30 | evidence 0001385187-12-000011 |
| FY 2010 | $10.4B | 2009-09-30 – 2010-09-30 | evidence 0001385187-12-000011 |
| FY 2009 | $10.3B | 2008-09-27 – 2009-09-25 | evidence 0001193125-10-266360 |
| FY 2008 | $9.9B | 2007-09-29 – 2008-09-26 | evidence 0001193125-10-266360 |
| FY 2007 | $9.3B | 2006-09-30 – 2007-09-28 | evidence 0001193125-09-239236 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).